@gan-Gans, your increasingly irrelevant comments and now almost hysterical down ramping in the face of excellent results totally convinces me MSB has the goods.
What you wrote is in blatant defiance of the facts and is evidence of panic in the shorters' ranks. To quote you "they deserve to lose".
Do you really think you fool anybody? You use language strongly critical of the CLBP results and yet do not offer even one word of scientific appraisal. The reason being, of course, that you have no ability to appraise them.
"Trial flop"? "not clinically meaningful"? Go on, put up some facts. And include the opioid users' results to support the flop claim.
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-595
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.33 |
Change
0.045(3.50%) |
Mkt cap ! $1.518B | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.35 | $1.30 | $2.885M | 2.183M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.33 | 7070 | 1 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |